Last update 27 Feb 2026

YKYY029

Overview

Basic Info

Drug Type
siRNA
Synonyms-
Target
AGT
Action
inhibitors
Mechanism
AGT inhibitors(Angiotensinogen inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential HypertensionHypertension
Inactive Indication-
Originator Organization
Yuekang Pharmaceutical Group Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.
Active Organization
Hangzhou Tianlong Pharmaceutical Co., Ltd.Hangzhou Tianlong Pharmaceutical Co., Ltd.Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

2
Clinical Trials associated with YKYY029
CTR20252860
/ Active, not recruitingPhase 1
评估YKYY029注射液单次皮下注射在中国健康志愿者及原发性轻度高血压患者中的安全性、耐受性、药代动力学/药效学的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of a single subcutaneous injection of YKYY029 injection in Chinese healthy volunteers and patients with essential mild hypertension
ChiCTR2500106480
/ Not yet recruitingPhase 1IIT
Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics of single subcutaneous injection of YKYY029 injection in Chinese healthy volunteers and patients with primary mild hypertension
100 Clinical Results associated with YKYY029
Login to view more data
100 Translational Medicine associated with YKYY029
Login to view more data
100 Patents (Medical) associated with YKYY029
Login to view more data
100 Deals associated with YKYY029
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 1
China
-23 Jul 2025
HypertensionIND Approval
United States
Yuekang Pharmaceutical Group Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.
23 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free